1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc.

RVPH
Reviva Pharmaceuticals Holdings, Inc.US flagNASDAQ Capital Market
0.60
USD
+0.00
- -
2.03MMarket Cap

Income Statement (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
- -
2
10
28
40
31
20
+ Selling, General & Admin
- -
2
5
5
8
8
8
+ Research & Development
- -
- -
5
23
31
23
12
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
- -
-2
-10
-28
-40
-31
-20
- Non-Operating (Income) Loss
- -
1
-2
- -
- -
-1
- -
+ Interest Expense, Net
- -
1
- -
- -
- -
- -
- -
+ Interest Expense
- -
1
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
-2
- -
- -
-1
- -
Pretax Income
-1
-4
-9
-28
-39
-30
-20
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-1
-4
-9
-28
-39
-30
-20
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-1
-4
-9
-28
-39
-30
-20
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-4
-9
-28
-39
-30
-20
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-1
-4
-9
-28
-39
-30
-20
EBIT
- -
-2
-10
-28
-40
-31
-20
EBITDA
- -
-2
-10
-28
-40
-31
-20
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
EBITA
- -
-2
-10
-28
-40
-31
-20
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
1
1
1
2
4
Basic EPS, GAAP
-6.11
-24.71
-11.52
-28.96
-32.99
-18.05
-5.48
Basic EPS from Cont Ops
-6.11
-24.71
-11.52
-28.96
-32.99
-18.05
-5.48
Diluted Weighted Avg Shares
- -
- -
1
1
1
2
4
Diluted EPS, GAAP
-6.11
-24.71
-11.52
-28.96
-32.99
-18.05
-5.48
Diluted EPS from Cont Ops
-6.11
-24.71
-11.52
-28.96
-32.99
-18.05
-5.48

Balance Sheet (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
- -
9
31
19
24
15
15
+ Cash, Cash Equivalents & STI
- -
9
30
19
23
13
14
+ Cash & Cash Equivalents
- -
9
30
19
23
13
14
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
2
- -
- -
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
- -
1
1
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
1
1
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
1
1
Total Assets
- -
9
31
19
24
16
16
+ Payables & Accruals
3
1
2
9
16
14
6
+ Accounts Payable
- -
1
1
4
4
6
3
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
3
- -
2
6
12
7
3
+ ST Debt
4
- -
- -
- -
- -
- -
- -
+ ST Borrowings
4
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
1
1
1
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
1
1
1
- -
Total Current Liabilities
7
1
2
10
17
15
7
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
2
- -
1
1
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
2
- -
1
1
- -
- -
Total Noncurrent Liabilities
- -
2
- -
1
1
- -
- -
Total Liabilities
7
3
3
11
18
15
7
+ Preferred Equity and Hybrid Capital
29
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
19
64
96
103
140
165
193
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
19
64
96
103
140
165
193
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-55
-58
-67
-95
-134
-164
-184
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-7
5
29
8
6
1
9
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
-7
5
29
8
6
1
9
Total Liabilities & Equity
- -
9
31
19
24
16
16
Shares Outstanding
9
- -
1
1
1
2
6
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
Net Debt
4
-9
-30
-19
-23
-13
-14
Net Debt to Equity
-55.27
-160.28
-103.49
-220.63
-408.61
-1,602.1
-162.26
Tangible Common Equity Ratio
-1,380,054
62.38
91.35
44.36
24.13
5.24
54.31
Current Ratio
- -
6.57
13.39
1.9
1.38
1.01
2.08
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-1
-4
-9
-28
-39
-30
-20
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
2
-1
- -
4
1
2
+ Stock-Based Compensation
- -
- -
- -
- -
3
2
2
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
2
-2
- -
- -
-1
- -
+ Chg in Non-Cash Work Cap
1
-2
-1
9
7
-5
-7
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-2
1
- -
-2
1
+ Inc (Dec) in Accts Payable
1
- -
1
8
7
-3
-7
+ Inc (Dec) in Other
- -
-2
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
-4
-11
-19
-28
-34
-25
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
31
8
27
23
19
+ Increase in Capital Stock
- -
- -
31
8
27
23
19
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
3
- -
- -
- -
- -
- -
+ Cash From Debt
- -
3
- -
- -
1
1
- -
+ Repayments of Debt
- -
- -
- -
- -
-1
-1
- -
+ Other Financing Activities
- -
9
- -
- -
6
- -
7
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
13
32
8
33
24
26
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
9
21
-11
5
-10
1
EBITDA
- -
-2
-10
-28
-40
-31
-20
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
- -
-4
-11
-19
-28
-34
-25
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-30
-11
-19
-28
-33
-25
Free Cash Flow per Basic Share
-1.58
-26.56
-14.43
-19.43
-23.8
-20.24
-6.78
Price/Free Cash Flow
-132.67
-6.58
-4.01
-4.37
-4.33
-1.79
-0.82
Cash Flow to Net Income
0.26
1.07
1.25
0.67
0.72
1.12
1.24
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -